Efficacy of Oxygen Therapy Delivered by Systems Using Oxygen-Saving Valves in COPD Patients
Not Applicable
Recruiting
- Conditions
- LUNG DISEASES, OBSTRUCTIVE
- Registration Number
- NCT01180803
- Lead Sponsor
- Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche
- Brief Summary
The purpose of this study is to compare the efficacy of oxygen therapy delivered by systems using oxygen-saving valves or not (continuous oxygen). We aim to determine if systems using oxygen-saving valves are equally effective as continuous oxygen delivery systems in reducing exercise-induced hypoxemia in patients with COPD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- COPD on necessity of long term oxygen therapy
- Able to give their written consent
Exclusion Criteria
- Unstable patients with COPD
- Patients with restrictive respiratory disease
- Patients with cardiac or neurologic disease contre-indicating the different evaluations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method oxygen saturation during 6 minutes walking test 1 day
- Secondary Outcome Measures
Name Time Method Walking distance during the 6 minutes walking test 1 day
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie oxygen-saving valve efficacy in COPD hypoxemia management?
How do pulse oxygen devices compare to continuous flow in COPD exercise-induced hypoxemia trials?
Which biomarkers correlate with improved oxygenation using demand-valve systems in obstructive lung disease?
What adverse events are associated with oxygen-conserving devices versus continuous delivery in COPD patients?
Are there synergistic effects when combining oxygen-saving valves with bronchodilators in COPD therapy?
Trial Locations
- Locations (1)
Fédération ANTADIR
🇫🇷Paris, France
Fédération ANTADIR🇫🇷Paris, FranceJacqueline DELRIEU, Ph. DContact+33.1.56.81.40.60delrieu@antadir.comBoris MELLONI, PrPrincipal Investigator
